Skip to main content
Article thumbnail
Location of Repository

Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder

By Ivon Cuscó, Andrés Medrano, Blanca Gener, Mireia Vilardell, Fátima Gallastegui, Olaya Villa, Eva González, Benjamín Rodríguez-Santiago, Elisabet Vilella, Miguel Del Campo and Luis A. Pérez-Jurado

Abstract

Autism spectrum disorders (ASDs) constitute a group of severe neurodevelopmental conditions with complex multifactorial etiology. In order to explore the hypothesis that submicroscopic genomic rearrangements underlie some ASD cases, we have analyzed 96 Spanish patients with idiopathic ASD after extensive clinical and laboratory screening, by array comparative genomic hybridization (aCGH) using a homemade bacterial artificial chromosome (BAC) array. Only 13 of the 238 detected copy number alterations, ranging in size from 89 kb to 2.4 Mb, were present specifically in the autistic population (12 out of 96 individuals, 12.5%). Following validation by additional molecular techniques, we have characterized these novel candidate regions containing 24 different genes including alterations in two previously reported regions of chromosome 7 associated with the ASD phenotype. Some of the genes located in ASD-specific copy number variants act in common pathways, most notably the phosphatidylinositol signaling and the glutamatergic synapse, both known to be affected in several genetic syndromes related with autism and previously associated with ASD. Our work supports the idea that the functional alteration of genes in related neuronal networks is involved in the etiology of the ASD phenotype and confirms a significant diagnostic yield for aCGH, which should probably be included in the diagnostic workup of idiopathic ASD

Topics: Articles
Publisher: Oxford University Press
OAI identifier: oai:pubmedcentral.nih.gov:2671988
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2008). A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism.
    2. (2007). A novel microdeletion at 16p11.2 harbors candidate genes for aortic valve development, seizure disorder, and mild mental retardation.
    3. (2008). Advances in autism genetics: on the threshold of a new neurobiology.
    4. (2001). Alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity.
    5. (1997). Annotation: tuberous sclerosis.
    6. (2006). Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders.
    7. (2008). Array-CGH in patients with Kabuki-like phenotype: identification of two patients with complex rearrangements including 2q37 deletions and no other recurrent aberration.
    8. (2008). Association between microdeletion and microduplication at 16p11.2 and autism.
    9. (2004). Association between the neurofibromatosis-1 (NF1) locus and autism in the Japanese population.
    10. (2003). Association of INPP1, PIK3CG, and TSC2 gene variants with autistic disorder: implications for phosphatidylinositol signalling in autism.
    11. (2004). Autism as a paradigmatic complex genetic disorder.
    12. (2008). Autism: many genes, common pathways?
    13. (2007). Autistic disorder and 22q11.2 duplication.
    14. (2000). Case with autistic syndrome and chromosome 22q13.3 deletion detected by FISH.
    15. (1997). Characterization of p150, an adaptor protein for the human phosphatidylinositol (PtdIns) 3-kinase. Substrate presentation by phosphatidylinositol transfer protein to the p150.Ptdins 3-kinase complex.
    16. (2007). Copy-number variation in control population cohorts.
    17. (2007). Discovery of a previously unrecognized microdeletion syndrome of 16p11.2–p12.2.
    18. (2006). Effects of the mGluR8 agonist (S)-3,4-DCPG in the lateral amygdala on acquisition/expression of fear-potentiated startle, synaptic transmission, and plasticity.
    19. (2008). Estradiol induces hypothalamic dendritic spines by enhancing glutamate Human Molecular Genetics,
    20. (2006). Fragile X syndrome and autism at the intersection of genetic and neural networks.
    21. (1997). Genetic influences in childhood-onset psychiatric disorders: autism and attention-deficit/hyperactivity disorder.
    22. (2006). Genetics of autism spectrum disorder.
    23. (2008). Genotype, haplotype and copy-number variation in worldwide human populations.
    24. (2007). Germ-line DNA copy number variation frequencies in a large North American population.
    25. (2006). High frequency of neurexin 1beta signal peptide structural variants in patients with autism.
    26. (2002). Identification of a novel gene on chromosome 7q11.2 interrupted by a translocation breakpoint in a pair of autistic twins.
    27. (2008). Identifying autism loci and genes by tracing recent shared ancestry.
    28. (2006). Increased serum levels of glutamate in adult patients with autism.
    29. (1993). Interactions between the glycine and glutamate binding sites of the NMDA receptor.
    30. (2000). KEGG: kyoto encyclopedia of genes and genomes.
    31. (2008). Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene.
    32. (2007). Mapping autism risk loci using genetic linkage and chromosomal rearrangements.
    33. (2008). mGluR-dependent long-term depression is associated with increased phosphorylation of S6 and synthesis of elongation factor 1A but remains expressed in S6K-deficient mice.
    34. (2008). Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatirc disorders.
    35. (2003). Model of autism: increased ratio of excitation/inhibition in key neural systems.
    36. (2008). Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders.
    37. (2003). mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo.
    38. (2007). Mutations in autism susceptibility candidate 2 (AUTS2) in patients with mental retardation.
    39. (2005). Mutations in PIP5K3 are associated with Francois–Neetens mouchetee fleck corneal dystrophy.
    40. (2007). Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.
    41. (2003). Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.
    42. (2005). Neurochemistry in the pathophysiology of autism.
    43. (2008). Neurofibromin is required for barrel formation in the mouse somatosensory cortex.
    44. (2008). Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder.
    45. (2007). PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data.
    46. (2007). Phosphatidylinositol 3-kinase and Akt nonautonomously promote perineurial glial growth in Drosophila peripheral nerves.
    47. (1999). Phosphorylation-dependent interaction of the N-methyl-D-aspartate receptor epsilon 2 subunit with phosphatidylinositol 3-kinase.
    48. (2008). Post-synaptic density-93 mediates tyrosine-phosphorylation of the N-methyl-D-aspartate receptors.
    49. (2000). Preferential association of syntaxin 8 with the early endosome.
    50. (2006). Pten regulates neuronal arborization and social interaction in mice.
    51. (2008). Role of mTOR in physiology and pathology of the nervous system.
    52. (2003). Routine cytogenetic and FISH studies for 17p11/15q11 duplications and subtelomeric rearrangement studies in children with autism spectrum disorders.
    53. (1997). Signalling through the lipid products of phosphoinositide-3-OH kinase.
    54. (2007). Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams–Beuren syndrome region.
    55. (2006). Stereological analysis of amygdala neuron number in autism.
    56. (2007). Strong association of de novo copy number mutations with autism.
    57. (2008). Structural variation of chromosomes in autism spectrum disorder.
    58. (2003). The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism.
    59. (2005). The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells.
    60. (2003). The prevalence of autism.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.